1.
Randomized,controlled trial of therapy for risedronate sodium capsules in postmenopausal osteoporosis
利塞膦酸钠胶囊治疗绝经后骨质疏松症
2.
Analysis on influencing factor of effect for treating postmenopausal osteoporosis with risedronate sodium capsules
利塞膦酸钠胶囊治疗绝经后骨质疏松症疗效的影响因素分析
3.
Effects of risedronate sodium on serum BGP and urine NTX/Cr in patients with postmenopausal osteoporosis
利塞膦酸钠对绝经后骨质疏松症患者血BGP及尿NTX/Cr的影响
4.
Measurements of Osteocalcin and Cross-linked N-telopeptide of Type 1 Collagen in Postmenopausal Osteoporosis and the Application of Risedronate in Its Prevention and Treatment;
绝经后骨质疏松症骨钙素和1型胶原交联氨基端肽测定意义以及利塞膦酸钠防治研究
5.
Effects of Risedronate on the Expression of Tumor Necrosis Factor Alpha and Osteoprotegrin in Human Osteoblastic-Like Cell Line MG63;
利塞膦酸钠对人成骨样细胞MG63护骨素及肿瘤坏死因子α表达的影响
6.
Risedronate Sodium effect of the osteogenesis induced by bone mesenchymal stem cells on decalcification bone scaffolds
利塞膦酸盐对BMSCs诱导的成骨细胞在脱钙骨支架上生物学行为的影响
7.
phosphonoacetic acid
膦酰乙酸，膦羧乙酸
8.
The effect of thalidomide and pamidronate incorporation with chemical therapy in the treatment of multiple myeloma
沙利度胺、帕米膦酸二钠联合化疗治疗多发性骨髓瘤的疗效观察
9.
Technetium[99mTc] Methylenediphosphonate
锝[99mTc]亚甲基二膦酸盐
10.
deoxyribonucleoside hydrogenphosphonate
脱氧（核糖）核苷氢膦酸酯
11.
deoxyribonucleoside methylphosphonate
脱氧（核糖）核苷膦酸甲酯
12.
Determination the Content of Celiprolol Hydrochloride Capsules by HPLC
HPLC法测定盐酸塞利洛尔胶囊的含量
13.
Determination of the content of Sodium alendronate in Sodium alendronate and calcitriol tablets by HPLC with precolumn derivatization
柱前衍生HPLC法测定阿仑膦酸钠骨化三醇片中阿仑膦酸钠的含量
14.
A Clinical Study of Zoledronic Acid and Ibandronate in Treatment of Pain Caused by Metastatic Bone Tumors
唑来膦酸及依班膦酸钠治疗恶性肿瘤骨转移疼痛的临床疗效观察
15.
The comparison of the clinical effects between ibandronate and alendronate in treatment of postmenopausal osteoporosis
伊班膦酸钠与阿仑膦酸钠对绝经后骨质疏松疗效的比较
16.
dexamethasone 21-acetate (INNM)
地塞米松21-醋酸酯（修改的国际非专利药品名称）
17.
Humic Acid Induced Growth Retardation in a Sertoli Cell Line,TM4
腐植酸诱导塞尔托利细胞系-TM4生长迟缓
18.
EXTRACTION OF RARE-EARTH IONS(Ⅲ) WITH BIS(2,4,4-TRIMETHYLPENTYL) PHOSPHINIC ACID
二(2,4,4-三甲基戊基)膦酸萃取稀土离子